Tag: post-marketing surveillance
How to Track Post-Marketing Studies for Drug Safety
Learn how post-marketing studies track drug safety after approval, using FAERS, Sentinel, and real-world data to catch hidden risks. Understand the systems, challenges, and future of pharmacovigilance.
view morerecent posts
Statin-induced muscle pain affects up to 30% of users, but most don't realize it's drug-related. Learn the real causes, what works to relieve it, and how to stay protected without giving up heart health.
Published ON: 9 MarStimulants like Adderall and Ritalin help manage ADHD but can increase the risk of dangerous heart rhythms, especially in older adults or those with hidden heart conditions. Learn how to assess your risk and what safer alternatives exist.
Published ON: 18 MarLearn how insurance policies treat generic and brand-name drugs differently-costs, substitution rules, Medicare vs commercial plans, and what to do if generics don’t work for you.
Published ON: 22 MarSwitching to generic medications saves up to 85% on prescription costs without sacrificing safety or effectiveness. Backed by FDA data and real patient outcomes, generics are the smart choice for long-term health and budgeting.
Published ON: 16 MarWhen no generic version of your medication exists, patient assistance programs can cut your drug costs to $0. Learn how to apply, what to expect, and the hidden traps that could leave you paying thousands anyway.
Published ON: 23 Mar